Concepedia

Early introduction of HMG-CoA reductase inhibitors could prevent the incidence of transplant coronary artery disease

Tadafumi Kato, T Tokoro, Y Namii, Takaaki Kobayashi, S Hayashi, Isao Yokoyama, S Morimoto, Michael Chan, Nadia Giannetti, Sharon A. Hunt

Transplantation Proceedings · 2000 · 25 citations · 19 references

Concepts

MedicineCardiologyPharmacologyCardiac TransplantationPreventive CardiologyTransplant SurgeryAtherosclerotic Cardiovascular Disease PreventionCardiovascular DiseaseCardiovascular Disease PreventionCoronary Artery DiseaseHeart TransplantationIschemic Heart DiseaseAtherosclerotic Disease PreventionCardiovascular Complications After TransplantationCoronary Artery Disease PharmacotherapyHmg-coa Reductase InhibitorsTransplant Coronary Artery Disease

References

19

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Scott M. Grundy · JAMA · 1993 · 27.9K citations

Medicine, Cardiology, Cardiovascular Pharmacotherapy +12

The Lipid Research Clinics Coronary Primary Prevention Trial Results

JAMA · 1984 · 2.8K citations

Medicine, Cardiology, Otolaryngology +9

Effect of Pravastatin on Outcomes after Cardiac Transplantation

Jon Kobashigawa, S Katznelson, Hillel Laks et al. · New England Journal of Medicine · 1995 · 1.3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Lipid Research Clinics Program

Roger A. Renfrew · JAMA · 1984 · 833 citations

Life Sciences, Nutritional Sciences, Pharmacotherapy +11

Simvastatin Reduces Graft Vessel Disease and Mortality After Heart Transplantation

K Wenke, Bruno Meiser, Joachim Thiery et al. · Circulation · 1997 · 450 citations

Medicine, Cardiology, Pharmacotherapy +17